$LLY

$1172.94▲ +1.1% YTD

4 SEC 13D/G filings tracked · Last updated Sep 1, 2026

Filing History

News

LLY ▲ +1.1% - Eli Lilly and Company

CP $1172.94▲ +1.1%Sep 1, 2026 · ThinkSabio Blog

$LLY - Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference…

News

LLY ▼ -0.2% - Eli Lilly and Company

CP $1170.00▲ -0.2%Aug 31, 2026 · ThinkSabio Blog

$LLY - New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in ad…

News

LLY ▼ -0.2% - Eli Lilly and Company

CP $1171.00▲ -0.2%Aug 31, 2026 · ThinkSabio Blog

$LLY - Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases…

News

LLY ▲ +0.9% - Eli Lilly and Company

CP $1185.61▲ +0.9%Aug 28, 2026 · ThinkSabio Blog

$LLY - FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes…